Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
D. Wright, Liona C. Poon, Daniel L. Rolnik, et al.
American Journal of Obstetrics and Gynecology (2017) Vol. 217, Iss. 6, pp. 685.e1-685.e5
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention
Liona C. Poon, Andrew Shennan, Jonathan Hyett, et al.
International Journal of Gynecology & Obstetrics (2019) Vol. 145, Iss. S1, pp. 1-33
Open Access | Times Cited: 862
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis
Stéphanie Roberge, Emmanuel Bujold, K. H. Nicolaides
American Journal of Obstetrics and Gynecology (2017) Vol. 218, Iss. 3, pp. 287-293.e1
Open Access | Times Cited: 502
Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
Min Yi Tan, Argyro Syngelaki, Liona C. Poon, et al.
Ultrasound in Obstetrics and Gynecology (2018) Vol. 52, Iss. 2, pp. 186-195
Open Access | Times Cited: 338
Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE
Min Yi Tan, D. Wright, Argyro Syngelaki, et al.
Ultrasound in Obstetrics and Gynecology (2018) Vol. 51, Iss. 6, pp. 743-750
Open Access | Times Cited: 306
Antiplatelet agents for preventing pre-eclampsia and its complications
Lelia Duley, Shireen Meher, Kylie E Hunter, et al.
Cochrane library (2019) Vol. 2019, Iss. 10
Open Access | Times Cited: 302
Prevention of preeclampsia with aspirin
Daniel L. Rolnik, K. H. Nicolaides, Liona C. Poon
American Journal of Obstetrics and Gynecology (2020) Vol. 226, Iss. 2, pp. S1108-S1119
Closed Access | Times Cited: 265
The exciting potential for ChatGPT in obstetrics and gynecology
Amos Grünebaum, Joseph Chervenak, Susan L. Pollet, et al.
American Journal of Obstetrics and Gynecology (2023) Vol. 228, Iss. 6, pp. 696-705
Closed Access | Times Cited: 181
Predictive performance of the competing risk model in screening for preeclampsia
D. Wright, Min Yi Tan, N. O’Gorman, et al.
American Journal of Obstetrics and Gynecology (2018) Vol. 220, Iss. 2, pp. 199.e1-199.e13
Open Access | Times Cited: 180
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history
Liona C. Poon, D. Wright, Daniel L. Rolnik, et al.
American Journal of Obstetrics and Gynecology (2017) Vol. 217, Iss. 5, pp. 585.e1-585.e5
Open Access | Times Cited: 170
ISUOG Practice Guidelines: role of ultrasound in screening for and follow‐up of pre‐eclampsia
Alexandros Sotiriadis, Edgar Hernández‐Andrade, Fabrício da Silva Costa, et al.
Ultrasound in Obstetrics and Gynecology (2018) Vol. 53, Iss. 1, pp. 7-22
Open Access | Times Cited: 157
Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
Piya Chaemsaithong, Ritsuko Pooh, Mingming Zheng, et al.
American Journal of Obstetrics and Gynecology (2019) Vol. 221, Iss. 6, pp. 650.e1-650.e16
Closed Access | Times Cited: 127
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
D. Wright, Daniel L. Rolnik, Argyro Syngelaki, et al.
American Journal of Obstetrics and Gynecology (2018) Vol. 218, Iss. 6, pp. 612.e1-612.e6
Open Access | Times Cited: 105
Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage
Stéphanie Roberge, Emmanuel Bujold, K. H. Nicolaides
American Journal of Obstetrics and Gynecology (2018) Vol. 218, Iss. 5, pp. 483-489
Open Access | Times Cited: 104
First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume
Jiri Sonek, David Krantz, Jon Carmichael, et al.
American Journal of Obstetrics and Gynecology (2017) Vol. 218, Iss. 1, pp. 126.e1-126.e13
Closed Access | Times Cited: 102
Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks’ gestation
Anca Marina Ciobanu, Angeliki Rouvali, Argyro Syngelaki, et al.
American Journal of Obstetrics and Gynecology (2019) Vol. 220, Iss. 5, pp. 486.e1-486.e11
Open Access | Times Cited: 95
A new model for screening for early-onset preeclampsia
Bernat Serra, Manel Mendoza, E. Scazzocchio, et al.
American Journal of Obstetrics and Gynecology (2020) Vol. 222, Iss. 6, pp. 608.e1-608.e18
Open Access | Times Cited: 93
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia
Liona C. Poon, Laura A. Magee, Stefan Verlohren, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 154, Iss. S1, pp. 3-31
Open Access | Times Cited: 68
Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia
Manel Mendoza, Erika Bonacina, Pablo Garcia‐Manau, et al.
JAMA (2023) Vol. 329, Iss. 7, pp. 542-542
Open Access | Times Cited: 29
Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps
L. Creswell, N. O’Gorman, Kirsten R. Palmer, et al.
International Journal of Women s Health (2023) Vol. Volume 15, pp. 255-271
Open Access | Times Cited: 25
Prevention of preeclampsia
Fiona Brownfoot, Daniel L. Rolnik
Best Practice & Research Clinical Obstetrics & Gynaecology (2024) Vol. 93, pp. 102481-102481
Open Access | Times Cited: 14
The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia
Stefan Verlohren, L Dröge
American Journal of Obstetrics and Gynecology (2020) Vol. 226, Iss. 2, pp. S1048-S1058
Closed Access | Times Cited: 60
Prediction of imminent preeclampsia at 35–37 weeks gestation
Anca Marina Ciobanu, A. Wright, Anca Maria Panaitescu, et al.
American Journal of Obstetrics and Gynecology (2019) Vol. 220, Iss. 6, pp. 584.e1-584.e11
Closed Access | Times Cited: 57
Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?
Piya Chaemsaithong, Diana Cuenca-Gómez, Nieves Plana, et al.
American Journal of Obstetrics and Gynecology (2019) Vol. 222, Iss. 5, pp. 437-450
Closed Access | Times Cited: 55
Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial
Anadeijda J. E. M. C. Landman, Marjon A. de Boer, Laura Visser, et al.
PLoS Medicine (2022) Vol. 19, Iss. 2, pp. e1003892-e1003892
Open Access | Times Cited: 30
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
Scott W. Walsh, Jerome F. Strauss
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6985-6985
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top